These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
760 related items for PubMed ID: 11039261
1. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options]. Gallar P, Ortega O, Gutiérrez M, Muñoz M, Hilara L, Oliet A, Rodríguez I, Giménez E, Vigil A. Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261 [Abstract] [Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
3. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients. Dong J, Wang H, Wang M. J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311 [Abstract] [Full Text] [Related]
4. RenaGel efficacy in severe secondary hyperparathyroidism. Castro R, Herman A, Ferreira C, Travassos F, Nunes-Azevedo J, Oliveira M. Nefrologia; 2002 Nov; 22(5):448-55. PubMed ID: 12497746 [Abstract] [Full Text] [Related]
5. Low calcium (2.5 mEq/l) and high calcium (3.5 mEq/l) dialysate in peritoneal dialysis patients. Wadhwa NK, Howell N, Suh H, Cabralda T. Adv Perit Dial; 1992 Nov; 8():385-8. PubMed ID: 1361829 [Abstract] [Full Text] [Related]
6. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study. Honkanen E, Kala AR, Grönhagen-Riska C, Ikäheimo R. Adv Perit Dial; 1992 Nov; 8():356-61. PubMed ID: 1361822 [Abstract] [Full Text] [Related]